Prostate Cancer Is Not a Side Effect of Testosterone Therapy

Prostate Cancer Is Not a Side Effect of Testosterone Therapy
Testosterone, a hormone given to men with hypogonadism, does not appear to increase the risk of prostate cancer, despite concerns in the scientific community. Ahmad Haider, MD, PhD, a urologist at Bremerhaven in Germany, led the investigation and published “Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , .

Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

Leave a Comment

Your email address will not be published. Required fields are marked *